Search Within

Department of Medicine

Formats
  1. Journal Article (19575)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22311)
  2. Hematologic Malignancies, Division of (13266)
  3. Center for Hematologic Malignancies (11051)
  4. GSK Faculty (10641)
  5. Survivorship Research (9324)
  6. Division of Subspecialty Medicine (7532)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1046)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4214)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39597)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MRI radiomics to predict outcome of neoadjuvant chemotherapy in patients with muscle invasive bladder cancer undergoing radical cystectomy
    Meeting Abstract

    Schwartz, L. H.; Akin, O.; Gold, S.; Deng, Y.; Lema-Dopico, A.; Chahwan, S.; Nincevic, J.; Ruby, L.; Capanu, M.; Apte, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of MTAP deletion on immunotherapy outcomes in patients with mesothelioma
    Meeting Abstract

    Ross, J.; Ortiz, E.; Barraza, G.; Mayoral, M.; Ginsberg, M. S.; Luongo, A.; Arfe, A.; Zauderer, M. G.; Adusumilli, P. S.; Eckert, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • EV-302: Long-term subgroup analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC)
    Meeting Abstract

    Bedke, J.; Powles, T.; Valderrama, B. P.; Gupta, S.; Kikuchi, E.; Loriot, Y.; Galsky, M D.; Sridhar, S. S.; Yu, E. Y.; Hoffman-Censits, J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy of second line (2L) treatment with tivozanib (Tivo) as monotherapy or with nivolumab (Nivo) in patients (pts) with metastatic renal cell carcinoma (mRCC) previously treated with an immune checkpoint inhibitor (ICI) combination of ipilimumab (Ipi)/Nivo or vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI)/ICI in the phase 3 TiNivo-2 study
    Meeting Abstract

    Chehrazi-Raffle, A.; Motzer, Robert J.; Beckermann, K.; Barthelemy, P.; Iacovelli, R.; Emambux, S.; Molina Cerrillomd, J.; Garmezy, B.; Barata, P. C.; McKay, R. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clear and non-clear cell renal cell carcinomas and the ability to engage in oxidative phosphorylation
    Meeting Abstract

    Bakouny, Z.; Boscenco, S.; Cui, R.; Ryu, K.; Kotecha, R. R.; Carlo, M.; Voss, M. H.; Hakimi, A. A.; Motzer, R. J.; Gammage, P. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Recent ADC approvals and their impact on the breast cancer space
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2025)

    Fulltext@MSK | Save
  • Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma
    Journal Article

    Xu, B.; Baine, M. K.; Jungbluth, A.; Alabkaa, A.; Serrette, R.; Roy, D.; Rudin, C. M.; Ho, A. L.; Sherman, E.; Dogan, S.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • Prenatal cell-free DNA sequencing and intrahepatic cholangiocarcinoma
    Journal Article

    Goldlust, I. S.; Gormally, M. V.; Teichholtz, S.; Turriff, A. E.; Harding, J. J.; Bianchi, D. W.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save